Notch1 increases Snail expression under high reactive oxygen species conditions in hepatocellular carcinoma cells

References

• Spangenberg HC, Thimme R, Blum HE. Targeted therapy for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009;6:423–432.
   PubMed Web of Science ®Google Scholar
• Zhou L, Rui JA, Ye DX, Wang SB, Chen SG, Qu Q. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg 2008;32:1748–1756.
   PubMedGoogle Scholar
• Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene 2006;25:3866–3884.
   PubMed Web of Science ®Google Scholar
• Treiber G. Systemic treatment of hepatocellular carcinoma. Dig Dis 2001;19:311–323.
   PubMed Web of Science ®Google Scholar
• Grego-Bessa J, Diez J, Timmerman L, de la Pompa JL. Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw. Cell Cycle 2004;3:718–721.
   PubMedGoogle Scholar
• Sahlgren C, Gustafsson MV, Jin S, Poellinger L, Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci U S A 2008; 105:6392–6397.
   PubMed Web of Science ®Google Scholar
• Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269–271.
   PubMed Web of Science ®Google Scholar
• Zardawi SJ, Zardawi I, McNeil CM, Millar EK, McLeod D, Morey AL, et al. High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype. Histopathology 2010;56: 286–296.
   PubMedGoogle Scholar
• Stylianou S, Clarke RB, Brennan K. Aberrant activation of notch signaling in human breast cancer. Cancer Res 2006; 66:1517–1525.
   PubMed Web of Science ®Google Scholar
• Lim SO, Park YM, Kim HS, Quan X, Yoo JE, Park YN, et al. Notch1 differentially regulates oncogenesis by wildtype p53 overexpression and p53 mutation in grade III hepatocellular carcinoma. Hepatology 2011;53:1352–1362.
   PubMed Web of Science ®Google Scholar
• Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276–285.
   PubMed Web of Science ®Google Scholar
• Batlle E, Sancho E, Francíi C, Dominguez D, Monfar M, Baulida J, Garciía De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2:84–89.
   PubMed Web of Science ®Google Scholar
• Kastl L, Sauer SW, Ruppert T, Beissbarth T, Becker MS, Suss D, et al. TNF-alpha mediates mitochondrial uncoupling and enhances ROS-dependent cell migration via NF-kappaB activation in liver cells. FEBS Lett 2014;588:175–183.
   PubMed Web of Science ®Google Scholar
• Szpaderska AM, Frankfater A. An intracellular form of cathepsin B contributes to invasiveness in cancer. Cancer Res 2001;61:3493–3500.
   PubMedGoogle Scholar
• Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S. Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005;129:1375–1383.
   PubMed Web of Science ®Google Scholar
• Mori K, Shibanuma M, Nose K. Invasive potential induced under long-term oxidative stress in mammary epithelial cells. Cancer Res 2004;64:7464–7472.
   PubMed Web of Science ®Google Scholar
• Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology 2008;135:2128–2140, 2140 e1–8.
   PubMed Web of Science ®Google Scholar
• Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nat Rev Cancer 2007;7:415–428.
   PubMed Web of Science ®Google Scholar
• Lim SO, Kim HS, Quan X, Ahn SM, Kim H, Hsieh D, et al. Notch1 binds and induces degradation of Snail in hepatocellular carcinoma. BMC Biol 2011;9:83.
   PubMedGoogle Scholar
• Kim HS, Jeong H, Lim SO, Jung G. Snail inhibits Notch1 intracellular domain mediated transcriptional activation via competing with MAML1. Biochem Biophys Res Commun 2013;433:6–10.
   PubMedGoogle Scholar
• Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503.
   PubMed Web of Science ®Google Scholar
• Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931–940.
   PubMed Web of Science ®Google Scholar
• Kohn AD, Takeuchi F, Roth RA. Akt, a pleckstrin homology domain containing kinase, is activated primarily by phosphorylation. J Biol Chem 1996;271:21920–21926.
   PubMed Web of Science ®Google Scholar
• Bresnick EH, Chu J, Christensen HM, Lin B, Norton J. Linking Notch signaling, chromatin remodeling, and T-cell leukemogenesis. J Cell Biochem Suppl 2000;Suppl 35:46–53.
   PubMedGoogle Scholar
• Kohler C, Bell AW, Bowen WC, Monga SP, Fleig W, Michalopoulos GK. Expression of Notch-1 and its ligand Jagged-1 in rat liver during liver regeneration. Hepatology 2004;39:1056–1065.
   PubMedGoogle Scholar
• Valenti L, Mendoza RM, Rametta R, Maggioni M, Kitajewski C, Shawber CJ, Pajvani UB. Hepatic notch signaling correlates with insulin resistance and nonalcoholic Fatty liver disease. Diabetes 2013;62:4052–4062.
   PubMed Web of Science ®Google Scholar
• Mo JS, Yoon JH, Ann EJ, Ahn JS, Baek HJ, Lee HJ, et al. Notch1 modulates oxidative stress induced cell death through suppression of apoptosis signal-regulating kinase 1. Proc Natl Acad Sci U S A 2013;110:6865–6870.
   PubMed Web of Science ®Google Scholar